These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of bronchoalveolar lavage in the assessment of diffuse lung diseases. Gibson PG; Robinson BW; McLennan G; Bryant DH; Breit SN Aust N Z J Med; 1989 Jun; 19(3):281-91. PubMed ID: 2775050 [TBL] [Abstract][Full Text] [Related]
4. Bronchoalveolar lavage in interstitial lung diseases: does the recovery rate affect the results? Schildge J; Nagel C; Grun C Respiration; 2007; 74(5):553-7. PubMed ID: 17496412 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic Utility of Bronchoalveolar Lavage Lymphocytosis in Patients with Interstitial Lung Diseases. Tzilas V; Digalaki A; Bouros E; Avdoula E; Tzouvelekis A; Bouros D Respiration; 2023; 102(11):944-947. PubMed ID: 37866357 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic approach of fibrosing interstitial lung diseases of unknown origin. Cottin V; Valenzuela C Presse Med; 2020 Jun; 49(2):104021. PubMed ID: 32437843 [TBL] [Abstract][Full Text] [Related]
9. Cytological analysis of bronchoalveolar lavage in patients with interstitial lung diseases and the relation of cytological analysis to fibrosis in high-resolution computed tomography. Espoladore LM; Gregório BB; Lima MS; de Pereira CA; Soares MR; Coletta EN Anal Quant Cytopathol Histpathol; 2014 Aug; 36(4):206-12. PubMed ID: 25291858 [TBL] [Abstract][Full Text] [Related]
10. Bronchoalveolar lavage: role in the evaluation of pulmonary interstitial disease. Hogea SP; Tudorache E; Pescaru C; Marc M; Oancea C Expert Rev Respir Med; 2020 Nov; 14(11):1117-1130. PubMed ID: 32847429 [TBL] [Abstract][Full Text] [Related]
15. Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter? Domagała-Kulawik J; Skirecki T; Maskey-Warzechowska M; Grubek-Jaworska H; Chazan R Inflammation; 2012 Jun; 35(3):803-9. PubMed ID: 21882075 [TBL] [Abstract][Full Text] [Related]
16. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases. Specks U; Martin WJ; Rohrbach MS Am Rev Respir Dis; 1990 Jan; 141(1):117-23. PubMed ID: 2153351 [TBL] [Abstract][Full Text] [Related]
17. NK and NKT cells in the diagnosis of diffuse lung diseases presenting with a lymphocytic alveolitis. Sokhatska O; Padrão E; Sousa-Pinto B; Beltrão M; Mota PC; Melo N; Delgado L; Morais A BMC Pulm Med; 2019 Feb; 19(1):39. PubMed ID: 30760244 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Welker L; Jörres RA; Costabel U; Magnussen H Eur Respir J; 2004 Dec; 24(6):1000-6. PubMed ID: 15572545 [TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases. Efared B; Ebang-Atsame G; Rabiou S; Diarra AS; Tahiri L; Hammas N; Smahi M; Amara B; Benjelloun MC; Serraj M; Chbani L; El Fatemi H J Negat Results Biomed; 2017 Mar; 16(1):4. PubMed ID: 28245857 [TBL] [Abstract][Full Text] [Related]
20. [Clinical value of diagnostic bronchoalveolar lavage in diffuse diseases of the lungs]. Khomenko AG; Shilling V; Filippov VP; Khmel'kova NG; Miuller S Probl Tuberk; 1987; (1):22-7. PubMed ID: 3562416 [No Abstract] [Full Text] [Related] [Next] [New Search]